2023 (v1)
Publication
No description
Uploaded on: February 6, 2024
R
M
Last name: RUSSELLO
First name: Maurizio
No description
Obeticholic acid (OCA) has recently been restricted in patients with primary biliary cholangitis (PBC) with "advanced cirrhosis" because of its narrow therapeutic index. We aimed at better defining the predicting factors of hepatic serious adverse events (SAEs) and non-response in cirrhotic patients undergoing OCA therapy.